Related references
Note: Only part of the references are listed.2019 ESC Guidelines for the dignosis and management of acute pulmonary embolism development Toed in colaboration with the European Respiratory Society (ERS)
Stavros Konstantinides et al.
EUROPEAN HEART JOURNAL (2020)
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis
Alexandre Sepriano et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
Yen-Ju Lin et al.
CELLS (2020)
Incidence of venous and arterial thromboembolic events reported in the tofacitinib rheumatoid arthritis, psoriasis and psoriatic arthritis development programmes and from real-world data
Philip Mease et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Atherosclerotic cardiovascular disease prevention in rheumatoid arthritis
Anne Grete Semb et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
From coagulation to inflammation: novel avenues for treating rheumatoid arthritis with activated protein C
Marie-Christophe Boissier et al.
RHEUMATOLOGY (2019)
Activated protein C targets immune cells and rheumatoid synovial fibroblasts to prevent inflammatory arthritis in mice
Meilang Xue et al.
RHEUMATOLOGY (2019)
Comparative Risk of Venous Thromboembolism in Rheumatoid Arthritis Patients Receiving Tofacitinib Versus Those Receiving Tumor Necrosis Factor Inhibitors: An Observational Cohort Study
Rishi J. Desai et al.
ARTHRITIS & RHEUMATOLOGY (2019)
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients
David R. Anderson et al.
BLOOD ADVANCES (2019)
Incidence of inpatient venous thromboembolism in treated patients with rheumatoid arthritis and the association with switching biologic or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in the real-world setting
Huifang Liang et al.
RMD OPEN (2019)
Risk of venous thromboembolism in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a general population-based cohort study
Alexis Ogdie et al.
EUROPEAN HEART JOURNAL (2018)
Thromboembolism with Janus Kinase (JAK) Inhibitors for Rheumatoid Arthritis: How Real is the Risk?
Ian C. Scott et al.
DRUG SAFETY (2018)
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
Jan Steffel et al.
EUROPEAN HEART JOURNAL (2018)
Management of major organ involvement of Behcet's syndrome: a systematic review for update of the EULAR recommendations
Yesim Ozguler et al.
RHEUMATOLOGY (2018)
Comparative Cardiovascular Risk of Abatacept and Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis With and Without Diabetes Mellitus: A Multidatabase Cohort Study
Eun Ha Kang et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis
A. Kapoor et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Venous thromboembolism and risk of cancer in patients with rheumatoid arthritis
A. B. Pedersen et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2017)
Thrombophilia Testing and Venous Thrombosis
Jean M. Connors
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
J. I. Weitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Reasons for the persistent incidence of venous thromboembolism
John A. Heit et al.
THROMBOSIS AND HAEMOSTASIS (2017)
The association between hydroxychloroquine treatment and cardiovascular morbidity among rheumatoid arthritis patients
Michael Shapiro et al.
Oncotarget (2017)
Tocilizumab: A Review in Rheumatoid Arthritis
Lesley J. Scott
DRUGS (2017)
The Association Between Rheumatoid Arthritis and Adverse Postoperative Outcomes: A Retrospective Analysis
Zhuo Sun et al.
ANESTHESIA AND ANALGESIA (2016)
Safety and Efficacy of Methotrexate in Psoriasis: A Meta-Analysis of Published Trials
Jonathan West et al.
PLOS ONE (2016)
Risk of Venous Thromboembolism in Patients with Rheumatoid Arthritis: Initiating Disease-Modifying Antirheumatic Drugs
Seoyoung C. Kim et al.
AMERICAN JOURNAL OF MEDICINE (2015)
Epidemiology of venous thromboembolism
John A. Heit
NATURE REVIEWS CARDIOLOGY (2015)
Methotrexate Is a JAK/STAT Pathway Inhibitor
Sally Thomas et al.
PLOS ONE (2015)
Non-steroidal anti-inflammatory drugs and risk of venous thromboembolism: a systematic review and meta-analysis
Patompong Ungprasert et al.
RHEUMATOLOGY (2015)
Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study
Wei-Sheng Chung et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials
N. van Es et al.
BLOOD (2014)
The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study
Hyon K. Choi et al.
ANNALS OF THE RHEUMATIC DISEASES (2013)
Apixaban for Extended Treatment of Venous Thromboembolism
Giancarlo Agnelli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
Lana A. Castellucci et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Use of Glucocorticoids and Risk of Venous Thromboembolism A Nationwide Population-Based Case-Control Study
Sigrun A. Johannesdottir et al.
JAMA INTERNAL MEDICINE (2013)
Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines
Clive Kearon et al.
CHEST (2012)
Risk of Venous Thromboembolism in Patients With Rheumatoid Arthritis and Association With Disease Duration and Hospitalization
Marie E. Holmqvist et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden
Bengt Zoller et al.
LANCET (2012)
Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis
Berthold Hoppe et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Prevalence of Specific Types of Arthritis and Other Rheumatic Conditions in the Ambulatory Health Care System in the United States, 2001-2005
Jeffrey J. Sacks et al.
ARTHRITIS CARE & RESEARCH (2010)
Severe atherosclerosis in rheumatoid arthritis and hyperhomocysteinemia: Is there a link?
Imane El Bouchti et al.
JOINT BONE SPINE (2008)
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States
Charles G. Helmick et al.
ARTHRITIS AND RHEUMATISM (2008)
The role of microparticles in inflammation and thrombosis
S. P. Ardoin et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2007)
The coagulation system in endocrine disorders: a narrative review
A. Squizzato et al.
INTERNAL AND EMERGENCY MEDICINE (2007)
Hyperhomocysteinemia and low B vitamin levels are independently associated with venous thromboembolism:: results from the EDITH study:: a hospital-based case-control study
E Oger et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Effects of short-term glucocorticoids on hemostatic factors in healthy volunteers
Daniel J. Brotman et al.
THROMBOSIS RESEARCH (2006)
The interactions between inflammation and coagulation
CT Esmon
BRITISH JOURNAL OF HAEMATOLOGY (2005)
The relationship between inflammation and venous thrombosis - A systematic review of clinical studies
EA Fox et al.
THROMBOSIS AND HAEMOSTASIS (2005)
Homocysteine in patients with rheumatoid arthritis in relation to inflammation and B-vitamin treatment
A Yxfeldt et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2003)
Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature
M Galli et al.
BLOOD (2003)
Clinical pharmacokinetics of leflunomide
B Rozman
CLINICAL PHARMACOKINETICS (2002)
Share Paper
